Daily Cosmetic Research Analysis
Analyzed 47 papers and selected 3 impactful papers.
Summary
A randomized surgical trial shows gasless endoscopic thyroidectomy via a subclavicular approach matches oncologic safety while improving anterior neck function and cosmetic satisfaction versus open surgery. Analytical profiling implicates rosin oxidation products in red tattoo inks as plausible haptens driving allergic reactions. A meta-analysis supports the inter-fascial (superficial–deep temporal fascia) plane with small-volume hyaluronic acid and larger-gauge cannulas for effective, cosmetically favorable temple augmentation.
Research Themes
- Minimally invasive oncologic surgery with superior cosmetic outcomes
- Chemical drivers of tattoo ink allergenicity
- Evidence-based optimization of hyaluronic acid filler techniques
Selected Articles
1. Functional and cosmetic advantages of gasless endoscopic thyroidectomy in papillary thyroid carcinoma: a randomized trial.
In a randomized comparison of 90 papillary thyroid carcinoma patients undergoing hemithyroidectomy with central neck dissection, gasless endoscopic surgery via a subclavicular approach matched open surgery in nodal yield, complications, and 6-month sonographic recurrence. ESSA significantly improved anterior neck sensory and motor function and cosmetic satisfaction.
Impact: This trial provides prospective randomized evidence that a minimally invasive technique can preserve function and enhance cosmetic outcomes without compromising short-term oncologic safety, informing surgical decision-making.
Clinical Implications: ESSA can be offered as an alternative to open thyroidectomy for PTC hemithyroidectomy+CND to improve patient-reported neck function and cosmetic satisfaction, with attention to longer-term oncologic follow-up.
Key Findings
- Lymph node yield was similar between ESSA and open surgery (9.04±4.58 vs 9.87±4.89; p=0.413), with comparable metastatic LN counts (p=0.874).
- No central neck lymph node recurrence detected by ultrasound at 6 months in either group.
- ESSA improved anterior neck sensory and motor outcomes (P=0.0217 and P=0.008) and had higher cosmetic satisfaction (P<0.001).
Methodological Strengths
- Randomized allocation with prospective data collection
- Multiple clinically relevant endpoints including function and patient-reported cosmetic satisfaction
Limitations
- Single-center study with short 6-month oncologic follow-up
- Blinding not feasible; potential performance and detection bias
Future Directions: Multicenter trials with longer oncologic follow-up and standardized functional/cosmetic outcome measures; cost-effectiveness and learning-curve analysis.
BACKGROUND: Conventional open surgery (OP) is effective and simple for treating papillary thyroid cancer (PTC), but the excessive separation of band strap muscles causes discomfort in the anterior cervical region and a long scar, which may impair the patient's life quality and beauty. Gasless endoscopic surgery via subclavicular approach (ESSA) may provide a better alternative. METHODS: The prospective data of 90 PTC patients who underwent ESSA or OP (45:45) in hemithyroidectomy and central neck dissection (CND) in our center from March 2022 to August 2023 were analyzed. Safety indicator incidence of complications, efficiency indicator No. lymph nodes (LNs) of CND, postoperative recurrence of central neck LNs indicated by Ultrasound (US) at 6 months, postoperative functions of the anterior cervical region and cosmetic satisfaction were recorded as the primary endpoints. RESULTS: The ESSA group had no significant differences with the OP group in baseline data, complications, No. LNs (9.04 ± 4.58 vs. 9.87 ± 4.89, p = 0.413) and metastatic LNs (1.60 ± 2.79 vs.1.69 ± 2.50, p = 0.874) of CND. The two groups had no postoperative recurrence of central neck LNs indicated by ultrasound (US) at 6 months. The ESSA group exhibited better functionally sensitive and motional outcomes in the anterior cervical region compared to the OP group (P = 0.0217 and P = 0.008), and had higher cosmetic satisfaction than the OP group (P < 0.001). CONCLUSION: Compared with OP, ESSA is equally safe and effective, but more cosmetic and conducive to preserving functions of the anterior cervical region. ESSA can be considered an alternative approach to OP in hemithyroidectomy and CND.
2. Determination of Rosin Oxidation Products in Pigments and Inks as a Potential Source of Tattoo Allergenicity.
Using advanced UHPLC/PDA/MS and HRMS analytics on 112 pigments and 119 inks, rosin oxidation products were detected broadly and enriched in red inks (~3-fold higher than non-red). The study proposes a manufacturing pathway whereby rosinated pigments yield persistent haptens, offering a mechanistic explanation for red tattoo allergies.
Impact: Identifying specific chemical species and production pathways linked to tattoo allergic reactions can immediately inform manufacturing choices, regulation, and clinical diagnostics.
Clinical Implications: Clinicians should consider ROP exposure in red tattoo reactions and advocate patch/usage testing for rosin-related allergens; manufacturers should avoid rosinated pigments or disclose ROP content.
Key Findings
- ROPs were detected in 32/112 pigments and 38/119 inks across brands.
- Red-spectrum inks had ~3-fold higher mean ROP levels than non-red inks.
- Azo pigments (PR170, PR266, PR22, PY74) and quinacridones (PR122, PV19) frequently co-occurred with ROPs; PR170 was present in 21 ROP-positive red inks.
- A manufacturing model implicates rosination pathways in generating allergenic haptens that persist in tissue.
Methodological Strengths
- Large cross-brand sampling with newly developed UHPLC/PDA/MS and HRMS methods
- Pigment-level and ink-level analyses enabling mechanistic inference to manufacturing steps
Limitations
- Chemical analytics without direct patient-level clinical correlation or dose–response thresholds
- Cross-sectional product sampling; lot-to-lot variability and aging not fully addressed
Future Directions: Link ROP quantification with clinical outcomes via patch testing and epidemiology; establish regulatory thresholds and validated analytical standards; explore detoxified pigment processes.
BACKGROUND: The vast majority of allergic tattoo reactions involve red-shaded tattoos without a causal explanation. OBJECTIVE: To determine rosin oxidation products (ROPs) in pigments and tattoo inks as a hypothesised source of tattoo allergenicity. MATERIALS AND METHODS: Content of pigment samples (n = 112) and tattoo inks (n = 119) was analysed using newly developed UHPLC/PDA/MS methods, XRD and high-resolution MS. RESULTS: ROPs were found at varying levels in 32 pigments and 38 tattoo inks. The mean ROP level of red inks was approximately three-fold higher than that of non-red-spectrum inks. Among 24 red-spectrum inks with ROPs, azo pigments PR170, PR266, PR22, PY74 and quinacridones PR122 and PV19 were frequently identified. PR170 was present in 21 of those inks. CONCLUSIONS: To explain results, a manufacturing model was developed showing rosination pathways, with only some having likely allergenic outcomes. Inks whose pigments were produced with rosin incorporated and/or irreversibly bound are the most likely to be allergenic. ROPs within those inks are believed to remain in the body after tattooing, acting as haptens. This view is consistent with biopsy reports of allergic reactions to red-shaded tattoos. We propose that ROPs may be at least partially responsible for those reactions. Pending proof of this proposal, tattoo-ink manufacturers might choose to avoid rosinated pigments.
3. Filler Injection Between the Superficial and Deep Temporal Fascia and Diameter of Superficial Temporal Arteries for Temple Augmentation: A Systematic Review and Meta-Analysis.
Across seven studies, hyaluronic acid filler injection between the superficial and deep temporal fascia achieved an 85% effectiveness rate, with best outcomes using 1.5 mL per side and 18G cannulas. The analysis supports small-volume, inter-fascial placement targeting supraperiosteal/supra-deep temporal fascia layers for effective and safe temple augmentation.
Impact: Synthesizes procedural parameters (plane, volume, cannula gauge) into actionable guidance for a high-risk anatomic area, potentially improving outcomes and safety.
Clinical Implications: Adopt inter-fascial (STF–DTF) placement with small volumes (~1.5 mL/side) and 18–21G cannulas for temple augmentation, with careful vascular mapping of the superficial temporal artery.
Key Findings
- Pooled effectiveness of inter-fascial HA filler injection was 85% (95% CI: 81–91%).
- Subgroup analysis: 1.5 mL per side yielded 94% effectiveness (95% CI: 77–100%).
- 18-gauge cannula achieved the highest effectiveness (94%; 95% CI: 77–100%), with 21G also recommended.
Methodological Strengths
- Systematic search across major databases with independent, blinded dual review
- Quantitative meta-analysis with subgroup analyses on volume and cannula gauge
Limitations
- Only seven studies with potential heterogeneity and variable outcome definitions
- Primarily non-randomized evidence; safety endpoints (e.g., vascular events) underreported
Future Directions: Prospective comparative trials with standardized aesthetic and safety outcomes, Doppler-guided protocols, and integration of superficial temporal artery caliber/variants.
BACKGROUND AND AIM: With age, temple depressions appear due to age-related atrophy of fatty tissue, leading to a prominent cheekbone and lateral rim of the eye socket. Hyaluronic acid fillers have become very popular in the temple area due to their simple procedure and reliable results. The present study was conducted with the aim of determining the effectiveness of filler injection between the superficial and deep temporal fascia and the diameter of superficial temporal arteries for temple enlargement. METHOD: The international databases PubMed, EMBASE, and Web of Science were searched using keywords aligned with the study objective up to July 2025. All articles were reviewed by two blinded, independent authors. STATA/MP.v17 (College Station, Texas, USA) was used to perform the analyses. RESULT: Based on the findings of seven included studies, the efficacy of HA filler injection in the STF and DTF area showed an efficacy of 85% (ES: 85%, 95% CI: 81%-91%). According to subgroup meta-analysis, higher efficacy was observed with volume injection of 1.5 mL on each side (ES: 94%, 95% CI: 77%-100%). Subgroup meta-analysis showed that the 18-gauge cannula had the highest effectiveness (ES: 94%, 95% CI: 77%-100%). CONCLUSION: For temple augmentation, hyaluronic acid filler injection between the superficial and deep temporal fasciae is a highly effective and safe procedure; it is also recommended to inject filler in small volumes and use 18-gauge and 21-gauge cannulas to target the supraperiosteal and supra-deep temporal fascia layers.